[시장보고서]1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine 시장 규모, 점유율, 동향 분석 보고서 : 용도별, 지역별, 부문 예측(2025-2030년)

1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine 시장 규모, 점유율, 동향 분석 보고서 : 용도별, 지역별, 부문 예측(2025-2030년)

1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine Piperazine Market Size, Share & Trends Analysis Report By Application, By Region, And Segment Forecasts, 2025 - 2030

상품코드 : 1701621

리서치사 : Grand View Research

발행일 : 2025년 03월

페이지 정보 : 영문 80 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,828,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,311,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 13,279,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

시장 규모와 동향 :

세계의 1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine 시장 규모는 2024년에 5,550만 달러에 달했고 2025년부터 2030년에 걸쳐 CAGR 3.5%를 나타낼 것으로 예측됩니다.

1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine은 주로 항정신병제인 푸마르산 퀘티아핀의 제조에 사용되는 화학 중간체입니다. 정신분열증, 쌍극성 장애, 우울증 등의 정신질환의 유병률 증가와 항정신병약의 세계 수요 증가가 1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine 수요를 크게 견인하고 있습니다.

1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine은 퀘티아핀 합성의 중요한 중간체이기 때문에 이러한 의약품에 대한 수요 증가는 1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine 시장에 직접 영향을 미칩니다.

일부 브랜드 항정신병제의 특허가 끊어진 것으로, 제네릭 의약품의 생산이 급증하고 1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine 수요를 더욱 밀어 올리고 있습니다. 화학적 합성 기술의 진보는 제약 회사에게 1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine을 더욱 매력적인 선택으로 삼고 있습니다. 또한 제약 업계에서 진행중인 연구 개발은 1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine의 새로운 치료 용도의 기회를 낳고 다양한 약제 제제에의 용도가 퍼질 가능성이 있습니다.

세계의 1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine 시장 전망
밸류체인 분석
- 원재료 전망
- 제조/기술 전망
- 판매 채널 분석
가격 동향 분석
- 가격에 영향을 미치는 요인
규제 프레임워크
시장 역학
- 시장 성장 촉진요인 분석
- 시장 성장 억제요인 분석
- 시장 과제 분석
- 시장 기회 분석
Porter's Five Forces 분석
- 공급기업의 협상력
- 구매자의 협상력
- 대체 위협
- 신규 참가업체의 위협
- 경쟁 기업간 경쟁 관계
PESTLE 분석
- 정치
- 경제
- 사회 환경
- 기술
- 환경
- 법률

제4장 1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine 시장 : 용도별 추정 및 동향 분석

1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine 시장 : 용도별 변동 분석(2023년, 2030년)
제약
화장품
농약
기타

제5장 1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine 시장 : 지역별 추정 및 동향 분석

지역별 분석(2023년, 2030년)
북미
- 용도별(2018-2030년)
- 미국
- 캐나다
- 멕시코
유럽
- 용도별(2018-2030년)
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
아시아태평양
- 용도별(2018-2030년)
- 중국
- 인도
- 일본
- 한국
라틴아메리카
- 용도별(2018-2030년)
- 브라질
- 아르헨티나
중동 및 아프리카
- 용도별(2018-2030년)
- 남아프리카
- 사우디아라비아

제6장 경쟁 구도

주요 시장 진출기업의 최근 동향
기업 분류
기업의 시장 점유율 분석(2024년)
기업의 시장 포지셔닝 분석(2024년)
생산능력(2024년)
전략 매핑
기업 프로파일/목록
- Valeshvar Biotech
- Tokyo Chemical Industry(India) Pvt. Ltd.
- Shanghai Ruifu Chemical Co., Ltd.
- Surya Life Sciences Ltd.
- Suzhou Jingye Medicine &Chemical Co., Ltd.

KTH

영문 목차

영문목차

Market Size & Trends:

The global 1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine market size was estimated at USD 55.5 million in 2024 and is projected to grow at a CAGR of 3.5% from 2025 to 2030. 1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine (HEEP) is a chemical intermediate primarily used in the production of Quetiapine Fumarate, an antipsychotic medication. It is also being explored for potential use in other pharmaceutical formulations. The growing prevalence of psychiatric disorders such as schizophrenia, bipolar disorder, and depression, combined with the increasing demand for antipsychotic drugs globally, has significantly driven the demand for HEEP.

As HEEP is a crucial intermediate in the synthesis of Quetiapine, the rising demand for such medications directly impacts the market for HEEP. Furthermore, the expansion of pharmaceutical production capacity, particularly in the generic drug sector, also contributes to market growth.

With the expiration of patents for several branded antipsychotic drugs, there has been a surge in the production of generic alternatives, which further drives the demand for HEEP. Technological advancements in the chemical synthesis of HEEP, including more efficient and cost-effective manufacturing processes, have made it an even more attractive option for pharmaceutical companies. Additionally, ongoing research and development in the pharmaceutical industry are creating opportunities for new therapeutic applications of HEEP, potentially broadening its uses in various drug formulations.

Global 1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine Market Report Segmentation

This report forecasts revenue and volume growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global 1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine market report based on the application and region.

Application Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)
Pharmaceuticals
Cosmetics
Agrochemicals
Others
Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
Asia Pacific
- China
- India
- Japan
- South Korea
Latin America
- Brazil
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
- 1.3.1. Information Analysis
- 1.3.2. Market Formulation & Data Visualization
- 1.3.3. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook

Chapter 3. Market Variables, Trends, and Scope

3.1. Global 1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine (HEEP) Market Outlook
3.2. Value Chain Analysis
- 3.2.1. Raw Material Outlook
- 3.2.2. Manufacturing/Technology Outlook
- 3.2.3. Sales Channel Analysis
3.3. Price Trend Analysis
- 3.3.1. Factors Influencing Prices
3.4. Regulatory Framework
3.5. Market Dynamics
- 3.5.1. Market Driver Analysis
- 3.5.2. Market Restraint Analysis
- 3.5.3. Market Challenges Analysis
- 3.5.4. Market Opportunity Analysis
3.6. Porter's Five Forces Analysis
- 3.6.1. Bargaining Power of Suppliers
- 3.6.2. Bargaining Power of Buyers
- 3.6.3. Threat of Substitution
- 3.6.4. Threat of New Entrants
- 3.6.5. Competitive Rivalry
3.7. PESTLE Analysis
- 3.7.1. Political
- 3.7.2. Economic
- 3.7.3. Social Landscape
- 3.7.4. Technology
- 3.7.5. Environmental
- 3.7.6. Legal

Chapter 4. 1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine (HEEP) Market: Application Estimates & Trend Analysis

4.1. 1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine (HEEP) Market: Application Movement Analysis, 2023 & 2030
4.2. Pharmaceuticals
- 4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
4.3. Cosmetics
- 4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
4.4. Agrochemicals
- 4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
4.5. Others
- 4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)

Chapter 5. 1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine (HEEP) Market: Regional Estimates & Trend Analysis

5.1. Regional Analysis, 2023 & 2030
5.2. North America
- 5.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
- 5.2.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
- 5.2.3. U.S.
  - 5.2.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
  - 5.2.3.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
- 5.2.4. Canada
  - 5.2.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
  - 5.2.4.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
- 5.2.5. Mexico
  - 5.2.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
  - 5.2.5.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
5.3. Europe
- 5.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
- 5.3.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
- 5.3.3. Germany
  - 5.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
  - 5.3.3.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million) (Kilotons)
  - 5.3.3.3. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
- 5.3.4. UK
  - 5.3.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
  - 5.3.4.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
- 5.3.5. France
  - 5.3.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
  - 5.3.5.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
- 5.3.6. Italy
  - 5.3.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
  - 5.3.6.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
- 5.3.7. Spain
  - 5.3.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
  - 5.3.7.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
5.4. Asia Pacific
- 5.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
- 5.4.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
- 5.4.3. China
  - 5.4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
  - 5.4.3.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
- 5.4.4. India
  - 5.4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
  - 5.4.4.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
- 5.4.5. Japan
  - 5.4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
  - 5.4.5.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
- 5.4.6. South Korea
  - 5.4.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
  - 5.4.6.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
5.5. Latin America
- 5.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
- 5.5.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
- 5.5.3. Brazil
  - 5.5.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
  - 5.5.3.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
- 5.5.4. Argentina
  - 5.5.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
  - 5.5.4.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
5.6. Middle East & Africa
- 5.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
- 5.6.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
- 5.6.3. South Africa
  - 5.6.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
  - 5.6.3.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
- 5.6.4. Saudi Arabia
  - 5.6.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
  - 5.6.4.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)

Chapter 6. Competitive Landscape

6.1. Recent Developments by Key Market Participants
6.2. Company Categorization
6.3. Company Market Share Analysis, 2024
6.4. Company Market Positioning Analysis, 2024
6.5. Production Capacities, 2024
6.6. Strategy Mapping
6.7. Company Profiles/Listing
- 6.7.1. Valeshvar Biotech
  - 6.7.1.1. Company Overview
  - 6.7.1.2. Financial Performance
  - 6.7.1.3. Product Benchmarking
- 6.7.2. Tokyo Chemical Industry (India) Pvt. Ltd.
  - 6.7.2.1. Company Overview
  - 6.7.2.2. Financial Performance
  - 6.7.2.3. Product Benchmarking
- 6.7.3. Shanghai Ruifu Chemical Co., Ltd.
  - 6.7.3.1. Company Overview
  - 6.7.3.2. Financial Performance
  - 6.7.3.3. Product Benchmarking
- 6.7.4. Surya Life Sciences Ltd.
  - 6.7.4.1. Company Overview
  - 6.7.4.2. Financial Performance
  - 6.7.4.3. Product Benchmarking
- 6.7.5. Suzhou Jingye Medicine & Chemical Co., Ltd.
  - 6.7.5.1. Company Overview
  - 6.7.5.2. Financial Performance
  - 6.7.5.3. Product Benchmarking